Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' OPARIL S' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 228 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Sun, JZ; Oparil, S; Lucchesi, P; Thompson, JA; Chen, YF
      Tyrosine kinase receptor activation inhibits NPR-C in lung arterial smoothmuscle cells

      AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
    2. Pool, J; Kaihlanen, P; Lewis, G; Ginsberg, D; Oparil, S; Glazer, R; Messerli, FH
      Once-daily treatment of patients with hypertension: a placebo-controlled study of amlodipine and benazepril vs amlodipine or benazepril alone

      JOURNAL OF HUMAN HYPERTENSION
    3. Tolbert, T; Oparil, S
      Cardiovascular effects of estrogen

      AMERICAN JOURNAL OF HYPERTENSION
    4. Fang, ZW; Carlson, SH; Chen, YF; Oparil, S; Wyss, JM
      Estrogen depletion induces NaCl-sensitive hypertension in female spontaneously hypertensive rats

      AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
    5. Thakkar, RB; Oparil, S
      What do international guidelines say about therapy?

      JOURNAL OF HYPERTENSION
    6. Tolbert, T; Thompson, JA; Bouchard, P; Oparil, S
      Estrogen-induced vasoprotection is independent of inducible nitric oxide synthase expression - Evidence from the mouse carotid artery ligation model

      CIRCULATION
    7. Perry, GJ; Mori, T; Wei, CC; Xu, XY; Chen, YF; Oparil, S; Lucchesi, P; Dell'Italia, LJ
      Genetic variation in angiotensin-converting enzyme does not prevent development of cardiac hypertrophy or upregulation of angiotensin II in response to aortocaval fistula

      CIRCULATION
    8. Tolbert, T; Oparil, S
      Hormone replacement therapy and stroke are the results surprising?

      CIRCULATION
    9. Oparil, S
      Blood pressure and beyond: Treating the cardiovascular disease complex with perindopril - Introduction

      AMERICAN JOURNAL OF CARDIOLOGY
    10. Oparil, S
      Efficacy of perindopril in the treatment of systemic hypertension

      AMERICAN JOURNAL OF CARDIOLOGY
    11. Oparil, S; Aurup, P; Snavely, D; Goldberg, A
      Efficacy and safety of losartan/hydrochlorothiazide in patients with severe hypertension

      AMERICAN JOURNAL OF CARDIOLOGY
    12. Dahlof, B; Devereux, R; de Faire, U; Fyhrquist, F; Nieminen, MS; Ibsen, H; Julius, S; Kjeldsen, S; Kristianson, K; Lederballe-Pedersen, O; Lindholm, LH; Omvik, P; Oparil, S; Wedel, H
      Losartan intervention for endpoint reduction in hypertension: The LIFE study

      CLINICAL TRIALS IN HYPERTENSION
    13. Calhoun, DA; Oparil, S
      The National Health and Nutrition Examination Survey III - How are we doing with blood pressure control?

      HYPERTENSION MEDICINE
    14. Tumlin, JA; Dunbar, LM; Oparil, S; Buckalew, V; Ram, CV; Mathur, V; Ellis, D; McGuire, D; Fellmann, J; Luther, RR
      Fenoldopam, a dopamine agonist, for hypertensive emergency: A multicenter randomized trial

      ACADEMIC EMERGENCY MEDICINE
    15. Rosenthal, T; Oparil, S
      Hypertension in women

      JOURNAL OF HUMAN HYPERTENSION
    16. Resnick, LM; Oparil, S; Chait, A; Haynes, RB; Kris-Etherton, P; Stern, JS; Clark, S; Holcomb, S; Hatton, DC; Metz, JA; McMahon, M; Pi-Sunyer, FX; McCarron, DA
      Factors affecting blood pressure responses to diet: The vanguard study

      AMERICAN JOURNAL OF HYPERTENSION
    17. Kjeldsen, SE; Dahlof, B; Devereux, RB; Julius, S; de Faire, U; Fyhrquist, F; Ibsen, H; Kristianson, K; Lederballe-Pedersen, O; Lindholm, LH; Nieminen, MS; Omvik, P; Oparil, S; Wedel, H
      Lowering of blood pressure and predictors of response in patients with left ventricular hypertrophy: The LIFE study

      AMERICAN JOURNAL OF HYPERTENSION
    18. Oparil, S
      Newly emerging pharmacologic differences in angiotensin II receptor blockers

      AMERICAN JOURNAL OF HYPERTENSION
    19. Peng, N; Wei, CC; Oparil, S; Wyss, JM
      The organum vasculosum of the lamina terminalis regulates noradrenaline release in the anterior hypothalamic nucleus

      NEUROSCIENCE
    20. Chen, YF; Oparil, S
      Endothelin and pulmonary hypertension

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    21. Furberg, CD; Wright, JT; Davis, BR; Cutler, JA; Alderman, M; Black, H; Cushman, W; Grimm, R; Haywood, LJ; Leenen, F; Oparil, S; Perry, HM; Probstfield, J; Whelton, P; Payne, G; Nwachuku, C; Gordon, D; Proschan, M; Frommer, P; Einhorn, P; Hawkins, M; Ford, C; Pressel, S; Piller, L; Lusk, C; Bettencourt, J; Kimmel, B; Geraci, T; Walsh, S; Rahman, M; Juratovac, A; Pospisil, R; Brennan, K; Carroll, L; Sullivan, S; Barone, G; Christian, R; Feldman, S; Lucente, T; Lewis, CE; Jenkins, K; McDowell, P; Johnson, J; Kingry, C; Letterer, R; Margolis, K; Holland, L; Jaeger-Fox, B; Williamson, J; Louis, G; Ragusa, P; Williard, A; Ferguson, RS; Tanner, J; Eckfeldt, J; Crow, R; Pelosi, J
      Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone - The Antihypertensive and Lipid-Lowering Treatment toPrevent Heart Attack Trial (ALLHAT)

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    22. Oparil, S; Bakir, SE
      Calcium antagonists in cardiovascular disease: Clinical evidence from morbidity and mortality trials

      DRUGS
    23. Carretero, OA; Oparil, S
      Essential hypertension part II: Treatment

      CIRCULATION
    24. Carretero, OA; Oparil, S
      Essential hypertension Part I: Definition and etiology

      CIRCULATION
    25. Li, GH; Chen, YF; Kelpke, SS; Oparil, S; Thompson, JA
      Estrogen attenuates integrin-beta(3)-dependent adventitial fibroblast migration after inhibition of osteopontin production in vascular smooth muscle cells

      CIRCULATION
    26. Bakir, S; Mori, T; Durand, J; Chen, YF; Thompson, JA; Oparil, S
      Estrogen-induced vasoprotection is estrogen receptor dependent - Evidence from the balloon-injured rat carotid artery model

      CIRCULATION
    27. Li, GH; Chen, SJ; Oparil, S; Chen, YF; Thompson, JA
      Direct in vivo evidence demonstrating neointimal migration of adventitial fibroblasts after balloon injury of rat carotid arteries

      CIRCULATION
    28. Metz, JA; Stern, JS; Kris-Etherton, P; Reusser, ME; Morris, CD; Hatton, DC; Oparil, S; Haynes, B; Resnick, LM; Pi-Sunyer, FX; Clark, S; Chester, L; McMahon, M; Snyder, GW; McCarron, DA
      A randomized trial of improved weight loss with a prepared meal plan in overweight and obese patients - Impact on cardiovascular risk reduction

      ARCHIVES OF INTERNAL MEDICINE
    29. Chen, YF; Oparil, S
      Endothelial dysfunction in the pulmonary vascular bed

      AMERICAN JOURNAL OF THE MEDICAL SCIENCES
    30. Messerli, FH; Oparil, S; Feng, ZB
      Comparison of efficacy and side effects of combination therapy of angiotensin-converting enzyme inhibitor (Benazepril) with calcium agonist (either nifedipine or amlodipine) versus high-dose calcium antagonist monotherapy for systemic hypertension

      AMERICAN JOURNAL OF CARDIOLOGY
    31. Mori, T; Durand, J; Chen, YF; Thompson, JA; Bakir, S; Oparil, S
      Effects of short-term estrogen treatment on the neointimal response to balloon injury of rat carotid artery

      AMERICAN JOURNAL OF CARDIOLOGY
    32. Barr, SI; McCarron, DA; Heaney, RP; Dawson-Hughes, B; Berga, SL; Stern, JS; Oparil, S
      Effects of increased consumption of fluid milk on energy and nutrient intake, body weight, and cardiovascular risk factors in healthy older adults

      JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION
    33. Koch, B; Oparil, S; Stimpel, M
      Co-administration of an ACE-inhibitor (moexipril) and hormonal replacementtherapy in postmenopausal women

      JOURNAL OF HUMAN HYPERTENSION
    34. Oparil, S; Aronson, S; Deeb, GM; Epstein, M; Levy, JH; Luther, RR; Prielipp, R; Taylor, A
      Fenoldopam: A new parenteral antihypertensive - Consensus roundtable on the management of perioperative hypertension and hypertensive crises

      AMERICAN JOURNAL OF HYPERTENSION
    35. Hedner, T; Oparil, S; Rasmussen, K; Rapelli, A; Gatlin, M; Kobi, P; Sullivan, J; Oddou-Stock, P
      A comparison of the angiotensin II antagonists valsartan and losartan in the treatment of essential hypertension

      AMERICAN JOURNAL OF HYPERTENSION
    36. Oparil, S
      Management of the hypertensive patient with coronary artery disease

      AMERICAN JOURNAL OF HYPERTENSION
    37. Oparil, S
      Treating multiple-risk hypertensive populations

      AMERICAN JOURNAL OF HYPERTENSION
    38. Mosca, L; Grundy, SM; Judelson, D; King, K; Limacher, M; Oparil, S; Pasternak, R; Pearson, TA; Redberg, RF; Smith, SC; Winston, M; Zinberg, S
      Guide to preventive cardiology for women

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    39. Oparil, S
      Hormones and vasoprotection

      HYPERTENSION
    40. Sever, PS; Oparil, S
      Unexplored territories with calcium channel blockers: Potential for the future - Official Satellite Symposium for the XVIIIth Congress of the European Society of Cardiology the National Exhibition Centre, Birmingham, United Kingdom August 28, 1994 - Introduction

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    41. Oparil, S
      Long-term morbidity and mortality trials with amlodipine

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    42. Pi-Sunyer, FX; Maggio, CA; McCarron, DA; Reusser, ME; Stern, JS; Haynes, RB; Oparil, S; Kris-Etherton, P; Resnick, LM; Chait, A; Morris, CD; Hatton, DC; Metz, JA; Snyder, GW; Clark, S; McMahon, M
      Multicenter randomized trail of a comprehensive prepared meal program in type 2 diabetes

      DIABETES CARE
    43. Alberts, BM; Ayala, FJ; Botstein, D; Frank, E; Holmes, EW; Lee, RD; Macagno, ER; Marrack, P; Oparil, S; Orkin, SH; Rubenstein, AH; Slayman, CW; Sparling, PF; Squire, LR; von Hippel, PH; Yamamoto, KR
      Science policy - Proposed changes for NIH's Center for Scientific Review

      SCIENCE
    44. Chrysant, GS; Bakir, S; Oparil, S
      Dietary salt reduction in hypertension - What is the evidence and why is it still controversial?

      PROGRESS IN CARDIOVASCULAR DISEASES
    45. Wolkowicz, PE; Urthaler, F; Forrest, C; Shen, H; Durand, J; Wei, CC; Oparil, S; Dell'Italia, LJ
      2-tetradecylglycidic acid, an inhibitor of carnitine palmitoyltransferase-1, induces myocardial hypertrophy via the AT1 receptor

      JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
    46. Su, XF; Wei, CC; Machida, N; Bishop, SP; Hankes, GH; Dillon, AR; Oparil, S; Dell'Italia, LJ
      Differential expression of angiotensin-converting enzyme and chymase in dogs with chronic mitral regurgitation

      JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
    47. Su, XF; Brower, G; Janicki, JS; Chen, YF; Oparil, S; Dell'Italia, LJ
      Differential expression of natriuretic peptides and their receptors in volume overload cardiac hypertrophy in the rat

      JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
    48. August, P; Oparil, S
      Hypertension in women

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    49. Oparil, S
      Eprosartan versus enalapril in hypertensive patients with angiotensin-converting enzyme inhibitor-induced cough

      CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL
    50. Wei, CC; Meng, QC; Palmer, R; Hageman, GR; Durand, J; Bradley, WE; Farrell, DM; Hankes, GH; Oparil, S; Dell'Italia, LJ
      Evidence for angiotensin-converting enzyme- and chymase-mediated angiotensin II formation in the interstitial fluid space of the dog heart in vivo

      CIRCULATION
    51. Mosca, L; Grundy, SM; Judelson, D; King, K; Limacher, M; Oparil, S; Pasternak, R; Pearson, TA; Redberg, RF; Smith, SC; Winston, M; Zinberg, S
      Guide to preventive cardiology for women

      CIRCULATION
    52. Dell'Italia, LJ; Oparil, S
      Bradykinin in the heart - Friend or foe?

      CIRCULATION
    53. Oparil, S
      Harriet Pearson Dustan

      CIRCULATION
    54. Li, GH; Chen, YF; Greene, GL; Oparil, S; Thompson, JA
      Estrogen inhibits vascular smooth muscle cell-dependent adventitial fibroblast migration in vitro

      CIRCULATION
    55. Oparil, S; Chen, SJ; Chen, YF; Durand, JN; Allen, L; Thompson, JA
      Estrogen attenuates the adventitial contribution to neointima formation ininjured rat carotid arteries

      CARDIOVASCULAR RESEARCH
    56. Oparil, S; Oberman, A
      Nontraditional cardiovascular risk factors

      AMERICAN JOURNAL OF THE MEDICAL SCIENCES
    57. Chait, A; Malinow, MR; Nevin, DN; Morris, CD; Eastgard, RL; Kris-Etherton, P; Pi-Sunyer, FX; Oparil, S; Resnick, LM; Stern, JS; Haynes, RB; Hatton, DC; Metz, JA; Clark, S; McMahon, M; Holcomb, S; Reusser, ME; Snyder, GW; McCarron, DA
      Increased dietary micronutrients decrease serum homocysteine concentrations in patients at high risk of cardiovascular disease

      AMERICAN JOURNAL OF CLINICAL NUTRITION
    58. Oparil, S; Levine, JH; Zuschke, CA; Gradman, AH; Ripley, E; Jones, DW; Hardison, JD; Cushing, DJ; Prasad, R; Michelson, EL
      Effects of Candesartan cilexetil in patients with severe systemic hypertension

      AMERICAN JOURNAL OF CARDIOLOGY
    59. Oparil, S
      Candesartan cilexetil in combination with low-dose hydrochlorothiazide is effective in severe hypertension

      AMERICAN JOURNAL OF CARDIOLOGY
    60. Hayes, RB; Kris-Etherton, P; McCarron, DA; Oparil, S; Chait, A; Resnick, LM; Morris, CD; Clark, S; Hatton, DC; Metz, JA; McMahon, M; Holcomb, S; Snyder, GW; Pi-Sunyer, FX; Stern, JS
      Nutritionally complete prepared meal plan to reduce cardiovascular risk factors: A randomized clinical trial

      JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION
    61. Heaney, RP; McCarron, DA; Dawson-Hughes, B; Oparil, S; Berga, SL; Stern, JS; Barr, SI; Rosen, CJ
      Dietary changes favorably affect bone remodeling in older adults

      JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION
    62. OPARIL S; DURAND J; CHEN SJ; CHEN YF; THOMPSON JA
      ESTROGEN INCREASES APOPTOSIS FOLLOWING ARTERY BALLOON INJURY IN OVARIECTOMIZED RATS

      Journal of investigative medicine
    63. FALLON MB; ABRAMS GA; ABDELRAZEK TT; DAI J; CHEN SJ; CHEN YF; LUO B; OPARIL S; KU DD
      GARLIC PREVENTS HYPOXIC PULMONARY-HYPERTENSION IN RATS

      American journal of physiology. Lung cellular and molecular physiology
    64. OPARIL S
      CASE-STUDY

      American journal of hypertension
    65. MCCARRON DA; OPARIL S; RESNICK LM; CHAIT A; HAYNES RB; KRISETHERTON P; PISUNYER FX; STERN JS; MORRIS CD; CLARK S; HATTON DC; METZ JA; MCMAHON M; HOLCOMB S; SNYDER GW
      COMPREHENSIVE NUTRITION PLAN IMPROVES CARDIOVASCULAR RISK-FACTORS IN ESSENTIAL-HYPERTENSION

      American journal of hypertension
    66. BIEDERMAN RWW; DOYLE M; YOUNG A; THRUPP S; KORTRIGHT E; PERRY G; BELLA J; DEVEREAUX R; OPARIL S; POHOST GM; DELLITALIA LJ
      EVIDENCE FOR MARKED DISPROPORTIONATE MYOCARDIAL DYSFUNCTION IN THE SEPTUM IN HYPERTENSIVE LEFT-VENTRICULAR HYPERTROPHY

      Journal of the American College of Cardiology
    67. OPARIL S
      COMPARISON OF EPROSARTAN AND ENALAPRIL ON INCIDENCE OF COUGH IN PATIENTS WITH ESSENTIAL-HYPERTENSION

      Journal of hypertension
    68. NEUTEL J; FRISHMAN N; OPARIL S; PAPADEMITRIOU V; GUTHRIE G
      A COMPARISON OF TELMISARTAN WITH LISINOPRIL IN PATIENTS WITH MILD-TO-MODERATE HYPERTENSION

      Journal of hypertension
    69. Dahlof, B; Devereux, RB; Julius, S; Kjeldsen, SE; Beevers, G; de Faire, U; Fyhrquist, F; Hedner, T; Ibsen, H; Kristianson, K; Lederballe-Pedersen, O; Lindholm, LH; Nieminen, MS; Omvik, P; Oparil, S; Wedel, H
      Characteristics of 9194 patients with left ventricular hypertrophy - The LIFE study

      HYPERTENSION
    70. OPARIL S; GUTHRIE R; LEWIN AJ; MARBURY T; REILLY K; TRISCARI J; WITCHER JA
      AN ELECTIVE-TITRATION STUDY OF THE COMPARATIVE EFFECTIVENESS OF 2 ANGIOTENSIN-II RECEPTOR BLOCKERS, IRBESARTAN AND LOSARTAN

      Clinical therapeutics
    71. Pool, J; Oparil, S; Hedner, T; Glazer, R; Oddou-Stock, P; Hester, A
      Dose-responsive antihypertensive efficacy of valsartan, a new angiotensin II-receptor blocker

      CLINICAL THERAPEUTICS
    72. SU XF; WEI CC; FARRELL DM; HANKES GH; DILLON SR; RYNDERS P; OPARIL S; SPINATE FG; DELLITALIA LJ
      DIFFERENTIAL-EFFECTS OF ANGIOTENSIN AT(1) RECEPTOR BLOCKADE ON ANG-IIPRODUCTION IN VOLUME OVERLOAD HEART-FAILURE

      Circulation
    73. WEI CC; FARRELL DM; BRADLEY WE; HAGEMAN G; HANKES GH; JAFFA A; OPARIL S
      RENIN-ANGIOTENSIN SYSTEM MODULATES BRADYKININ PRODUCTION IN THE DOG HEART IN-VIVO

      Circulation
    74. LI GH; CHEN YF; OPARIL S; THOMPSON JA
      ESTROGEN INDIRECTLY INHIBITS ADVENTITIAL FIBROBLAST MIGRATION

      Circulation
    75. FARRELL DM; WEI CC; BRADLEY WE; HAGEMAN G; BABU YS; CHEN YF; OPARIL S
      INHIBITION OF ANGIOTENSIN-II FORMATION IN THE DOG HEART IN-VIVO BY A NOVEL SERINE-PROTEASE INHIBITOR BCX-1470

      Circulation
    76. OPARIL S
      PATHOPHYSIOLOGY OF SUDDEN CORONARY DEATH IN WOMEN - IMPLICATIONS FOR PREVENTION

      Circulation
    77. STIMPEL M; KOCH B; OPARIL S
      ANTIHYPERTENSIVE TREATMENT IN POSTMENOPAUSAL WOMEN - RESULTS FROM A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, CONTROLLED-STUDY COMPARING AN ACE-INHIBITOR (MOEXIPRIL) WITH A DIURETIC (HYDROCHLOROTHIAZIDE)

      Cardiology
    78. REIF M; WHITE WB; FAGAN TC; OPARIL S; FLANAGAN TL; EDWARDS DT; CUSHING DJ; MICHELSON EL
      EFFECTS OF CANDESARTAN CILEXETIL IN PATIENTS WITH SYSTEMIC HYPERTENSION

      The American journal of cardiology
    79. OPARIL S; CALHOUN DA
      MANAGING THE PATIENT WITH HARD-TO-CONTROL HYPERTENSION

      American family physician
    80. Chen, YF; Oparil, S
      Effects of sex steroids in vascular injury

      ENDOCRINOLOGY OF CARDIOVASCULAR FUNCTION
    81. CALHOUN DA; OPARIL S
      HIGH BLOOD-PRESSURE IN WOMEN

      International journal of fertility and women's medicine
    82. WHITE CR; DARLEYUSMAR V; OPARIL S
      GENDER AND CARDIOVASCULAR-DISEASE - RECENT INSIGHTS

      Trends in cardiovascular medicine
    83. AVERSA CR; OPARIL S; CARO J; LI HB; SUN SD; CHEN YF; SWERDEL MR; MONTICELLO TM; DURHAM SK; MINCHENKO A; LIRA SA; WEBB ML
      HYPOXIA STIMULATES HUMAN PREPROENDOTHELIN-1 PROMOTER ACTIVITY IN TRANSGENIC MICE

      American journal of physiology. Lung cellular and molecular physiology
    84. OPARIL S
      DOSE-RESPONSE CHARACTERISTICS OF MIBEFRADIL, A NOVEL CALCIUM-ANTAGONIST, IN THE TREATMENT OF ESSENTIAL-HYPERTENSION (VOL 10, PG 735, 1997)

      American journal of hypertension
    85. DAHLOF B; DEVEREUX R; DEFAIRE U; FYHRQUIST F; HEDNER T; IBSEN H; JULIUS S; KJELDSEN S; KRISTIANSON K; LEDERBALLEPEDERSEN O; LINDHOLM LH; NIEMINEN MS; OMVIK P; OPARIL S; WEDEL H
      THE LOSARTAN INTERVENTION FOR END-POINT REDUCTION (LIFE) IN HYPERTENSION STUDY - RATIONALE, DESIGN, AND METHODS

      American journal of hypertension
    86. OPARIL S; KOBRIN I; ABERNETHY DR; LEVINE BS; REIF MC; SHEPHERD AM
      DOSE-RESPONSE CHARACTERISTICS OF MIBEFRADIL, A NOVEL CALCIUM-ANTAGONIST, IN THE TREATMENT OF ESSENTIAL-HYPERTENSION

      American journal of hypertension
    87. MCCARRON DA; WEDER AB; EGAN BM; KRISHNA GG; MORRIS CD; COHEN M; OPARIL S
      BLOOD-PRESSURE AND METABOLIC RESPONSES TO MODERATE SODIUM RESTRICTIONIN ISRADIPINE-TREATED HYPERTENSIVE PATIENTS

      American journal of hypertension
    88. MCCARRON DA; WEDER AB; EGAN BM; KRISHNA GG; MORRIS CD; COHEN M; OPARIL S
      BLOOD-PRESSURE AND METABOLIC RESPONSES TO MODERATE SODIUM RESTRICTIONIN ISRADIPINE-TREATED HYPERTENSIVE PATIENTS

      American journal of hypertension
    89. PROSCHAN M; DAVIS B; CUTLER J; FORD C; FURBERG C; GRIMM R; OPARIL S
      ALLHAT AND CALCIUM-CHANNEL BLOCKERS

      American journal of hypertension
    90. PROSCHAN M; DAVIS B; CUTLER J; FORD C; FURBERG C; GRIMM R; OPARIL S
      ALLHAT AND CALCIUM-CHANNEL BLOCKERS

      American journal of hypertension
    91. WYSS JM; PENG N; MENG QC; CHEN YF; OPARIL S
      THE ROLE OF ANTERIOR HYPOTHALAMIC AREA NORADRENALINE RELEASE IN SALT-SENSITIVE HYPERTENSION IN SPONTANEOUSLY HYPERTENSIVE RATS

      Fundamental and clinical pharmacology
    92. BALCELLS E; MENG QC; JOHNSON WH; OPARIL S; DELLITALIA LJ
      ANGIOTENSIN-II FORMATION FROM ACE AND CHYMASE IN HUMAN AND ANIMAL HEARTS - METHODS AND SPECIES CONSIDERATIONS

      American journal of physiology. Heart and circulatory physiology
    93. DELLITALIA LJ; BALCELLS E; MENG QC; SU XF; SCHULTZ D; BISHOP SP; MACHIDA N; STRAETERKNOWLEN IM; HANKES GH; DILLON R; CARTEE RE; OPARIL S
      VOLUME-OVERLOAD CARDIAC-HYPERTROPHY IS UNAFFECTED BY ACE-INHIBITOR TREATMENT IN DOGS

      American journal of physiology. Heart and circulatory physiology
    94. TIAN BH; MENG QC; CHEN YF; KREGE JH; SMITHIES O; OPARIL S
      BLOOD PRESSURES AND CARDIOVASCULAR HOMEOSTASIS IN MICE HAVING REDUCEDOR ABSENT ANGIOTENSIN-CONVERTING ENZYME GENE-FUNCTION

      Hypertension
    95. CHEN SJ; CHEN YF; OPGENORTH TJ; WESSALE JL; MENG QC; DURAND J; DICARLO VS; OPARIL S
      THE ORALLY-ACTIVE NONPEPTIDE ENDOTHELIN A-RECEPTOR ANTAGONIST A-127722 PREVENTS AND REVERSES HYPOXIA-INDUCED PULMONARY-HYPERTENSION AND PULMONARY VASCULAR REMODELING IN SPRAGUE-DAWLEY RATS

      Journal of cardiovascular pharmacology
    96. OPARIL S
      THE EXPANDING ROLE OF CALCIUM-ANTAGONISTS IN CARDIOVASCULAR-DISEASE -INTRODUCTION

      Clinical therapeutics
    97. DELBANCO TL; OPARIL S
      A 42-YEAR-OLD MAN WITH HYPERTENSION

      JAMA, the journal of the American Medical Association
    98. ALDERMAN MH; ANDERSON S; BENNETT WM; DRUEKE TB; HAYNES RB; KINCAIDSMITH PS; KURTZ TW; LARAGH JH; LINAS SL; LOGAN AG; LUFT FC; MANCIA G; MCCARRON DA; OPARIL S; STAESSEN JAH; STERN JS
      SCIENTISTS STATEMENT REGARDING DATA ON THE SODIUM-HYPERTENSION RELATIONSHIP AND SODIUM HEALTH CLAIMS ON FOOD LABELING

      Nutrition reviews
    99. CALHOUN D; OPARIL S; MATHUR V; LUTHER R; ELLIS D
      FENOLDOPAM - A NOVEL, PERIPHERALLY ACTING DOPAMINE-1 AGONIST FOR PARENTERAL TREATMENT OF HYPERTENSION

      Medicamentos de actualidad
    100. DELLITALIA LJ; MENG QC; BALCELLS E; WEI CC; PALMER R; HAGEMAN GR; DURAND J; HANKES GH; OPARIL S
      COMPARTMENTALIZATION OF ANGIOTENSIN-II GENERATION IN THE DOG HEART - EVIDENCE FOR INDEPENDENT MECHANISMS IN INTRAVASCULAR AND INTERSTITIAL SPACES

      The Journal of clinical investigation


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 23/10/20 alle ore 05:05:42